# Professor Aswath Damodaran's valuation of the healthcare industry is cited

Faculty News

— February 25, 2019

![Wall Street Journal logo](/sites/default/files/styles/246w/public/assets/images/wsjlogo.jpg?itok=5Qt0z3WX)

>

Excerpt from [The Wall Street Journal](https://www.wsj.com/articles/ges-biotech-miracle-cure-11551113590) -- "Valuation guru Aswath Damodaran late last year figured it was worth about $38 billion, while analysts at Deutsche Bank thought a disposal of part of the business would fetch a little over $10 billion after taxes."

[Read more](https://www.wsj.com/articles/ges-biotech-miracle-cure-11551113590)